Portal de Periódicos da CAPES

The Rapid Anticoagulation Prevents Ischemic Damage Study in Acute Stroke – Final Results from the Writing Committee

2005; Karger Publishers; Volume: 19; Issue: 6 Linguagem: Inglês

10.1159/000086100

1421-9786

Ángel Chamorro, O. Busse, Vı́ctor Obach, Danilo Toni, Peter Sandercock, Joan Carles Reverter, Álvaro Cervera, Ferrán Torres, Antoni Dávalos,

Antiplatelet Therapy and Cardiovascular Diseases

Research Articles| June 23 2005 The Rapid Anticoagulation Prevents Ischemic Damage Study in Acute Stroke – Final Results from the Writing Committee Subject Area: Cardiovascular System , Neurology and Neuroscience Á. Chamorro; Á. Chamorro aStroke Unit, Hemotherapy and Hemostasia Service, and Clinical Pharmacology Unit, Hospital Clínic, Barcelona, Search for other works by this author on: This Site PubMed Google Scholar O. Busse; O. Busse cStroke Unit, Minden Klinikum, Minden, Germany; Search for other works by this author on: This Site PubMed Google Scholar V. Obach; V. Obach aStroke Unit, Hemotherapy and Hemostasia Service, and Clinical Pharmacology Unit, Hospital Clínic, Barcelona, Search for other works by this author on: This Site PubMed Google Scholar D. Toni; D. Toni dStroke Unit, La Sapienza, Rome, Italy, and Search for other works by this author on: This Site PubMed Google Scholar P. Sandercock; P. Sandercock eDepartment of Clinical Neurosciences, Western General Hospital, Edinburgh, UK Search for other works by this author on: This Site PubMed Google Scholar J.C. Reverter; J.C. Reverter aStroke Unit, Hemotherapy and Hemostasia Service, and Clinical Pharmacology Unit, Hospital Clínic, Barcelona, Search for other works by this author on: This Site PubMed Google Scholar A. Cervera; A. Cervera aStroke Unit, Hemotherapy and Hemostasia Service, and Clinical Pharmacology Unit, Hospital Clínic, Barcelona, Search for other works by this author on: This Site PubMed Google Scholar F. Torres; F. Torres aStroke Unit, Hemotherapy and Hemostasia Service, and Clinical Pharmacology Unit, Hospital Clínic, Barcelona, Search for other works by this author on: This Site PubMed Google Scholar Á. Dávalos Á. Dávalos bStroke Unit, Hospital Josep Trueta, Girona, Spain; Search for other works by this author on: This Site PubMed Google Scholar Cerebrovasc Dis (2005) 19 (6): 402–404. https://doi.org/10.1159/000086100 Article history Published Online: June 23 2005 Content Tools Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation Á. Chamorro, O. Busse, V. Obach, D. Toni, P. Sandercock, J.C. Reverter, A. Cervera, F. Torres, Á. Dávalos; The Rapid Anticoagulation Prevents Ischemic Damage Study in Acute Stroke – Final Results from the Writing Committee. Cerebrovasc Dis 1 June 2005; 19 (6): 402–404. https://doi.org/10.1159/000086100 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsCerebrovascular Diseases Search Advanced Search Article PDF first page preview Close Modal This content is only available via PDF. © 2004 S. Karger AG, Basel2005Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. You do not currently have access to this content.